Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-23

Clinical Trial Update: Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT

View source ↗

Summary

This clinical trial update reports a completed comparison study of Rubidium-82 PET imaging versus Technetium-99m SPECT imaging in patients with coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rubidium-82 (rubidium-82)
  • Technetium-99m radiotracer (technetium-99m radiotracer (e.g., sestamibi/tetrofosmin))

Snippet

Sponsor: Hartford Hospital | Conditions: Coronary Artery Disease, Myocardial Ischemia | Status: COMPLETED